HCPLive staff

Erectile dysfunction (ED) may be a more common comorbidity than previously thought among patients with gout. Patients with gout may also be more likely to have severe ED.

Research shows febuxostat is more effective than allopurinol in reducing serum urate levels in patients with gout.

The addition of a topical corticosteroid to once-weekly etanercept produces similar outcomes among patients with moderate to severe plaque psoriasis as a regimen of twice weekly etanercept at the same dose.

Cosentyx (secukinumab) has been approved in Japan for the treatment of psoriasis vulgaris (also known as plaque psoriasis) and psoriatic arthritis.

Researchers compared the effectiveness of biologics approved in Europe for the treatment of plaque psoriasis based on their performance as measured by primary endpoints in clinical trials.

Patients with osteoporosis got some good news at a recent conference when the results of a study showed that taking the drug denosumab can help increase bone density and keep their rate of fractures at a low level.